AH ANNUAL REPORT 2018
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Priority 2<br />
Rationale<br />
Measuring<br />
Monitoring<br />
& Reporting<br />
No Preventable Harms or Deaths<br />
The Trust has made significant improvements in reducing the amount of harm being caused<br />
to patients, with medication errors causing harm being reduced by 75% and hospital acquired<br />
infections being reduced by over 45%. Patient safety remains a top priority for the Trust with the<br />
acknowledgement that there is always room for further improvement. Specific focus will be given to<br />
early intervention when patients begin to deteriorate unexpectedly, and to reducing the number of<br />
hospital acquired pressure ulcers.<br />
The Trust Board agree that there should be specific focus on:<br />
• Achieving zero preventable deaths in hospital<br />
• Early intervention for the deteriorating patient<br />
• Reduction in preventable pressure ulcers<br />
The number of preventable deaths will be taken as a high level proxy for this measure. Compliance<br />
with the national sepsis standards and the number of Grade 3 and 4 pressure ulcers will also be<br />
measured.<br />
The monthly corporate report will be used to monitor and report progress against these measures.<br />
This is reported through to Clinical Quality Assurance Committee and Trust Board. Sepsis standards<br />
are also reported nationally and form part of the quality contract with commissioners.<br />
Priority 3<br />
Rationale<br />
Measuring<br />
Monitoring<br />
& Reporting<br />
Outstanding Clinical Outcomes for Children<br />
The Trust is proud to be world leading in many areas of developing paediatric outcome measures<br />
and recognises there are further opportunities to develop and improve our monitoring of clinical<br />
outcomes. Part of this commitment links to the Trust’s desire to reduce variation and to strengthen<br />
standardisation of clinical pathways, thereby ensuring the best evidence based pratice is embedded<br />
and spread across the organisation. As a Global Digital Exemplar, the Trust is already committed<br />
to digitising clinical pathways and standardising documentation, using best practice as evidenced<br />
in NICE guidance and National Standards. This will form part of our priority to deliver outstanding<br />
clinical outcomes for children. Specific focus will also be given to further reducing hospital acquired<br />
infections as a key measure of improved clinical outcome.<br />
The Trust Board agree that there should be specific focus on:<br />
• Developing digitised clinical pathways<br />
• Developing and improving outcomes in each specialty<br />
• Reduction in hospital acquired infections<br />
The Trust will track the number of standardised / digitised pathways, plus bespoke outcome<br />
measures in each specialty. The number of hospital infections will also be used to demonstrate<br />
improvement in clinical outcomes.<br />
Evidence based, digitised care pathways will continue to be monitored through the bespoke Global<br />
Digital Excellence Steering Group and reported to the Trust’s Programme Board. Hospital Acquired<br />
Infections will be closely monitored by the Trust’s Infection Prevention and Control team and tracked<br />
monthly through the Trust’s corporate report, reporting ultimately to Clinical Quality Assurance<br />
Committee and Trust Board.<br />
Alder Hey Children’s NHS Foundation Trust 83<br />
Annual Report & Accounts 2017/18